Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alebund, Altimmune, Alto, Crispr, Edgewise, Gri, I-Mab, Invivyd, Lisata, Metabolics, Opus, Pfizer, Viatris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acaris, Ambry, Moleculight, Ossdsign, Vivos.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alvotech, Aprea, Assembly, Biogen, Blue Earth, Calcimedica, Hemab, Hoth, Innovent, Ionis, Kashiv, Phio, Qbiotics, Soleno.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiosense, Genedx, Glucotrack, Onetwo Analyics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abeona, Actuate, Biomarin, Breye, Brightgene, Corcept, Immunic, Lineage Cell, Mindrank, Nektar, Nuvalent, Perfuse, Rivus, Roche, Sana, Sangamo, Stuart, Thermosome, Veru.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Cidara, Compass, Eli Lilly, Exelixis, Forte, H. Lundbeck, Immutep, J&J, Leap, Merck, Novo Nordisk, Pleopharma, Roche, Vertex.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Amplia, Ascentage, D&D Pharmatech, F2G.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Fractyl Health, Irhythm, Medtronic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzinova, Capricor, Grifols, Zealand.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aptevo, Camurus, F2G, Galderma, Oncoinvent, Scholar Rock, Shionogi.